TickerFactsScreenerDevelopers

Karyopharm Therapeutics Inc. (KPTI) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $154.0K2017: $1.60M2018: $30.34M2019: $40.89M2020: $108.08M2021: $209.82M2022: $157.07M2023: $146.03M2024: $145.24M2025: $146.07M$146.07M
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$146.07M+0.6%
2024$145.24M-0.5%
2023$146.03M-7.0%
2022$157.07M-25.1%
2021$209.82M+94.1%
2020$108.08M+164.3%
2019$40.89M+34.8%
2018$30.34M+1790.1%
2017$1.60M+942.2%
2016$154.0K—